Financhill
Sell
50

LSB Quote, Financials, Valuation and Earnings

Last price:
$2.84
Seasonality move :
16.02%
Day range:
$2.60 - $3.50
52-week range:
$1.88 - $11.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.47x
P/B ratio:
0.66x
Volume:
124.9K
Avg. volume:
56.4K
1-year change:
-34.22%
Market cap:
$56.5M
Revenue:
$80.2M
EPS (TTM):
-$2.01

Earnings Data

Next earnings date for LSB
Apr 18
2025
Most recent earnings per share
-$1.57
Missed by $1.48
(Sep 30/2023)
Consensus Estimate
-$0.08
(Sep 30/2023)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

LSB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2024 Q4 -- -- -- -$0.06 --
12/20/2024 Q3 -- -- -- -$0.08 --
08/15/2024 Q2 -- -- -- -$0.09 --
04/19/2024 Q1 $21.8M -- -- -$0.08 --
12/31/2023 Q4 $19.8M -- -- -$0.06 --
09/30/2023 Q3 $20.2M $13.4M -$1.57 -$0.08 -$1.48
06/30/2023 Q2 -- $25.2M -$1.07 -- --
09/30/2022 Q3 -- $28.3M -$0.46 -- --
06/30/2022 Q2 -- $31.1M -$0.89 -- --

LakeShore Biopharma Earnings Questions

  • How Much did LakeShore Biopharma Generate in Revenue Last Quarter?

    LakeShore Biopharma reported $13.4M worth of top line sales in its most recent quarter.

  • Did LakeShore Biopharma Beat Earnings Last Quarter?

    LakeShore Biopharma announced earnings per share of -$1.57 which represents a miss of analyst forecast a -$0.08 per share.

  • Is LakeShore Biopharma Profitable?

    LakeShore Biopharma reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for LakeShore Biopharma EPS Next Year?

    LakeShore Biopharma's earnings are forecast to decrease from -$5.66 per share to -$0.45 per share next year representing a decrease of -56.61%.

  • When is LakeShore Biopharma's Earnings Date?

    LakeShore Biopharma's next earnings date is April 18, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock